Welcome to the international HTA database

Showing [3358 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: creation and characterization of a Québec lung cancer patient cohort using clinical administrative data]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: needs analysis grid for families followed by Integrated Perinatal and Early Childhood Services (SIPPE)]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: hospital at home, an alternative to conventional hospitalization]
2021	Ontario Health	Stance-control knee–ankle–foot orthoses for people with knee instability: a health technology assessment
2021	Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS)	[Training programming for healthcare professionals: How to support patients with chronic diseases to self-manage their health]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: evolving profile of the use and clinical outcomes of transcatheter aortic valve implantation (TAVI) and surgical aortic valve implantation (SAVR) in Québec, a real-world evaluation from 2013 to 2019]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: mammographic density and breast cancer screening]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: relevance of neonatal pulse oximetry screening for critical congenital heart disease]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: use of single-photon emission computed tomography with [ 123I]ioflupane (DaTscan) in the diagnostic process for parkinsonian syndromes]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: relevance of using mpMRI for the diagnostic investigation of prostate cancer - mpMRI and prostate cancer diagnosis]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: alcohol withdrawal and relapse prevention]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: long-term left ventricular assist devices, real-world evolving portrait of use and outcomes in Québec from 2010 to 2017]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: organization of care and services related to alternate levels of care (ALC)]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: oral opioid agonists for the treatment of opioid use disorder]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: challenging behaviours - best practices in prevention, assessment and Intervention for people with an intellectual disability, physical disability or autism spectrum disorder]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: efficacy and safety of buprenorphine and methadone for the treatment of opioid use disorder]
2021	Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS)	[Specific rehabilitation interventions for physical impairment to avoid chronification of non-specific back pain in adults]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: assessment and risk management of severe neurological complications following mild traumatic brain injury]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: administration of benzodiazepines or gabapentin prescribed via an individual prescription for alcohol withdrawal]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: efficacy and safety of pharmacological treatments for alcohol withdrawal and relapse prevention]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: initiating pharmacotherapy for relapse prevention in a person with alcohol use disorder]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: initiating blood work for the purpose of evaluating diagnosed or suspected alcohol use disorder]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: urinary catheter placement in an adult with functional autonomy decline presenting with symptoms suggestive of acute urinary retention]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: initiating diagnostic measures in a person with signs and symptoms suggestive of a urinary tract infection (cystitis or pyelonephritis) and initiating first-line pharmacological treatment for cystitis in an adult with functional autonomy decline]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: efficacy and safety of immunoglobulins in rheumatology. Systematic review report]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: optimal use of immunoglobulins in rheumatology. Report in support of the optimal use guide English summary]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: standards for the management of acute ST-segment elevation myocardial infarction (STEMI) in Québec (update of April 2021)]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: validation of the management framework for a nonspecific human immunoglobulin shortage]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: chronic” Lyme disease: current state of knowledge and overview of the different perspectives]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: clinical utility of the different Western blot antigen profiles in the context of disseminated Lyme disease]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Lyme disease and persistent symptoms: a look at the current knowledge and recommendations for improving management]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: Hemlibra (emicizumab) – Hemophilia A without inhibitor (re evaluation)]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: initiating pharmacological treatment for clearing an occluded central venous access device (CVAD)]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: artificial intelligence-assisted diabetic retinopathy tele-screening]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: noninvasive fetal RhD genotyping using maternal plasma]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: advisability of using molecular tests to clarify the diagnosis of thyroid nodules with indeterminate cytology]
2021	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: use of the SpaceOAR hydrogel rectal spacer during prostate radiotherapy]
2021	Ontario Health	Vaginal pessaries for pelvic organ prolapse and stress urinary incontinence
2021	Ontario Health	Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure
2021	Ontario Health	Proton Beam Therapy for Cancer in Children and Adults: A Health Technology Assessment
2021	Ontario Health	Pigmented lesion assay for suspected melanoma lesions
2021	Ontario Health	Repetitive Transcranial Magnetic Stimulation for People With Treatment-Resistant Depression
2021	Ontario Health	Skin substitutes for adults with diabetic foot ulcers and venous leg ulcers
2021	Ontario Health	Prostatic artery embolization for benign prostatic hyperplasia
2021	Ontario Health	Nonthermal endovenous treatments for varicose veins
2021	Ontario Health	Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment
2021	Ontario Health	DPYD Genotyping in Patients Who Have Planned Cancer Treatment With Fluoropyrimidines
2021	Ontario Health	iStent for Adults With Glaucoma: A Health Technology Assessment
2021	Ontario Health	Internet-delivered cognitive behavioral therapy for post-traumatic stress disorder and acute stress disorder
2021	Ontario Health	Enhanced Visualization Methods for First Transurethral Resection of Bladder Tumour in Suspected Non-muscle-invasive Bladder Cancer: A Health Technology Assessment
2020	Institute of Health Economics (IHE)	Urgent care models to bridge emergency and primary care
2020	Institute of Health Economics (IHE)	The effectiveness of community face mask use for the prevention of COVID-19 transmission and infection
2020	Institute of Health Economics (IHE)	COVID-19 transmission from and infection of children
2020	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Field evaluation of the implementation of video teleconsultations during the COVID-19 pandemic at the Quebec Heart and Lung Institute]
2020	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Exploratory evaluation of the relevance, use, and impacts of teleconsultations]
2020	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Proposal for the organization of bariatric medicine for the territories of the integrated university health and social services network of Laval University]
2020	Canadian Agency for Drugs and Technologies in Health (CADTH)	Condition-level review on tuberculosis: repository of evidence and resources
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal use guide: pharmacological treatment of sexually transmitted and blood-borne infections ─ infections caused by chlamydia trachomatis and neisseria gonorrhoeae]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: the therapeutic value of hyperbaric oxygen (HBO) on children with cerebral palsy]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: use of sedation and general anesthesia in pediatric dental care]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal use of immunoglobulins in clinical immunology]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal use of immunoglobulins in hematology]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: initiating a blood profile after detecting suggestive symptoms and signs of mild or major neurocognitive disorder]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: pharmacological treatment for fecal elimination in a person receiving palliative care or presenting a geriatric profile]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: first-line treatment of oral candidiasis in adults]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: tomosynthesis and breast cancer: diagnostic evaluation and other uses]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: Takhzyro (lanadelumab), notice of inclusion on the Liste des produits du système du sang du Québec]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: continuous glucose monitoring system (Dexcom G6, Dexcom)]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: recommendations concerning the information required to monitor nusinersen use in real-world settings]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: RebinynTM (nonacog beta pegol) – coagulation factor IX (recombinant), notice of inclusion on the Liste des produits du système du sang du Québec]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: evolving portrait of the use and clinical outcomes of transcatheter aortic valve implantation (TAVI) in Québec, an evaluation in the real-world context of care, 2013 to 2018]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: prevention of cardiovascular events and safety of SGLT2 inhibitors compared to DPP-4 inhibitors in a real-world setting in patients with type 2 diabetes]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: iStent® and iStent inject® trabecular bypass for micro-invasive glaucoma surgery (MIGS)]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: update of the systematic review of the effects of palivizumab prophylaxis on reducing complications associated with respiratory syncytial virus infections in children]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: safety of switching biologics and their interchangeability]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated in August 2020: administration of drugs prescribed via an individual prescription in the event of distress for a person receiving palliative care]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Summary: investigation, treatment and follow-up algorithm - lung cancer]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Rapid review: alternatives to timolol for the treatment of glaucoma]
2020	Technology Assessment at SickKids (TASK)	Microcosting of whole genome sequencing (WGS) of trios in heterogeneous pediatric cardiac population
2020	Ontario Health	Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment
2020	Ontario Health	Home narrowband ultraviolet B phototherapy for photoresponsive skin conditions
2020	Ontario Health	Automated CT perfusion imaging to aid in the selection of patients with acute ischemic stroke for mechanical thrombectomy
2020	Ontario Health	Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Valve Stenosis at Low Surgical Risk
2020	Ontario Health	Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment
2020	Ontario Health	Gene Expression Profiling Tests for Early-Stage Invasive Breast Cancer: A Health Technology Assessment
2020	Ontario Health	5-Aminolevulinic Acid Hydrochloride (5 ALA)–Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment
2020	Ontario Health	Extracorporeal Membrane Oxygenation for Cardiac Indications in Adults: A Health Technology Assessment
2020	Ontario Health	Continual Long-Term Physiotherapy After Stroke: A Health Technology Assessment
2020	Ontario Health	10-kHz high-frequency spinal cord stimulation for adults with chronic noncancer pain: a health technology assessment
2020	Ontario Health	Cell-Free Circulating Tumour DNA Blood Testing to Detect EGFR T790M Mutation in People With Advanced Non–Small Cell Lung Cancer: A Health Technology Assessment
2020	Ontario Health	Auditory Brainstem Implantation for Adults With Neurofibromatosis 2 or Severe Inner Ear Abnormalities: A Health Technology Assessment
2020	Ontario Health	Portable Normothermic Cardiac Perfusion System in Donation After Cardiocirculatory Death: A Health Technology Assessment
2020	Ontario Health	Transcatheter Aortic Valve Implantation in Patients With Severe, Symptomatic Aortic Valve Stenosis at Intermediate Surgical Risk: A Health Technology Assessment
2020	Ontario Health	Implantable devices for single-sided deafness and conductive or mixed hearing loss: a health technology assessment
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Portrait of coronary revascularization by percutaneous coronary intervention and coronary bypass grafting in Quebec, 2015-2018]
2019	Institute of Health Economics (IHE)	Clinical effectiveness and cost-effectiveness of Oncotype DX and Prosigna genetic testing in early-stage breast cancer
2019	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Evaluation of the effectiveness and cost effectiveness of cardiac rehabilitation programs]
2019	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Induction immunosuppressive therapy in patients undergoing heart transplantation]
2019	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Measurement of gastric residual volume during enteral feeding in patients hospitalized in the intensive care unit]
2019	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Use of incentive spirometry for the prevention of pulmonary complications following surgery]